Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Schuster

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Parasitology Today (Personal Ed.)|January 1, 1994
Medicinal plants in the fight against leishmaniasisM M Iwu, J E Jackson, B G Schuster
The Annals of Pharmacotherapy|February 26, 1998
Critical analysis of the pharmaceutical care research literatureN R Kennie, B G Schuster, T R Einarson
The Journal of Membrane Biology|November 1, 2013
The effect of endotoxin on thin lipid bilayer membranesB G Schuster, R F Palmer, R S Aronson
The Journal of Parasitology|April 29, 1999
Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicinM Grogl, B G Schuster, W Y Ellis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1979
Production of antibodies against phosphocholine, phosphatidylcholine, sphingomyelin, and lipid A by injection of liposomes containing lipid AB G Schuster, M Neidig, B M Alving, et al.
Clinical Pharmacology and Therapeutics|May 29, 2000
Mechanism of cardiotoxicity of halofantrineD L Wesche, B G Schuster, W X Wang, et al.
The American Journal of Tropical Medicine and Hygiene|May 23, 1998
First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarialR P Brueckner, K C Lasseter, E T Lin, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarialR P Brueckner, T Coster, D L Wesche, et al.
British Journal of Clinical Pharmacology|March 1, 1981
Normal pharmacokinetics of doxapramin in a patient with renal failure and hypothyroidismJ R Baker, C C Peck, B D Raybuck, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1994
Efficacy of azithromycin as a causal prophylactic agent against murine malariaS L Andersen, A L Ager, P McGreevy, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Parasitology Today (Personal Ed.)|January 1, 1994
Medicinal plants in the fight against leishmaniasisM M Iwu, J E Jackson, B G Schuster
The Annals of Pharmacotherapy|February 26, 1998
Critical analysis of the pharmaceutical care research literatureN R Kennie, B G Schuster, T R Einarson
The Journal of Membrane Biology|November 1, 2013
The effect of endotoxin on thin lipid bilayer membranesB G Schuster, R F Palmer, R S Aronson
The Journal of Parasitology|April 29, 1999
Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicinM Grogl, B G Schuster, W Y Ellis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1979
Production of antibodies against phosphocholine, phosphatidylcholine, sphingomyelin, and lipid A by injection of liposomes containing lipid AB G Schuster, M Neidig, B M Alving, et al.
Clinical Pharmacology and Therapeutics|May 29, 2000
Mechanism of cardiotoxicity of halofantrineD L Wesche, B G Schuster, W X Wang, et al.
The American Journal of Tropical Medicine and Hygiene|May 23, 1998
First-time-in-humans safety and pharmacokinetics of WR 238605, a new antimalarialR P Brueckner, K C Lasseter, E T Lin, et al.
Antimicrobial Agents and Chemotherapy|May 21, 1998
Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarialR P Brueckner, T Coster, D L Wesche, et al.
British Journal of Clinical Pharmacology|March 1, 1981
Normal pharmacokinetics of doxapramin in a patient with renal failure and hypothyroidismJ R Baker, C C Peck, B D Raybuck, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1994
Efficacy of azithromycin as a causal prophylactic agent against murine malariaS L Andersen, A L Ager, P McGreevy, et al.
Pageof 4